Skip to main content
. 2020 Mar 31;31(5):1067–1077. doi: 10.1681/ASN.2019070723

Figure 1.

Figure 1.

All of the biomarkers except for MCP-1 had the greatest number of CKD progression events in the fourth quartile. The unadjusted (A) and adjusted (B) incidence rates of CKD progression events according to quartile of plasma biomarker concentration. Estimates of adjusted incidence rates were controlled for age, glomerular diagnosis, proteinuria, and eGFR at baseline.